Guidelines by Topic

Multiple Myeloma (16)
Search within:  

Sort results by:      



Filter results by:

1-15 of 15  
 
1.  
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation. 2014 Apr. NGC:010349
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Multiple myeloma. 2013 Nov. NGC:010388
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Bortezomib in multiple myeloma and lymphoma. 2006 Apr 3 (revised 2013 Mar 18). NGC:010003
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Guidelines for the diagnosis and management of multiple myeloma 2013. 2006 Feb (revised 2013). NGC:010002
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
5.  
Lenalidomide in multiple myeloma. 2012 May 30. NGC:009789
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Stem cell transplantation in multiple myeloma. 2012 Mar 29. NGC:009865
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
ACR-ASTRO practice guideline for the performance of total body irradiation. 2001 (revised 2011). NGC:008769
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
8.  
ACR Appropriateness Criteria® non-spine bone metastases. 1996 (revised 2011). NGC:008877
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
9.  
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. 2002 Apr 18 (revised 2010 Nov 20). NGC:008178
American Society of Clinical Oncology - Medical Specialty Society; American Society of Hematology - Medical Specialty Society. View all guidelines by the developer(s)
10.  
11.  
Thalidomide in multiple myeloma. 2010 Jan 20. NGC:008036
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy. 2009 Jun. NGC:007383
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
15.  
ACR Appropriateness Criteria® spinal bone metastases. 1996 (revised 2012). NGC:009677
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
1-15 of 15